#United States #New York #Inc. #Securities Fraud #Merck & Co. #Gardasil

Levi & Korsinsky Files Class Action Lawsuit Against Merck & Co., Inc.

In recent developments, Levi & Korsinsky, LLP has notified investors about a class action lawsuit pertaining to Merck & Co., Inc. (NYSE: MRK). This lawsuit revolves around alleged securities fraud that has impacted investors between February 3, 2022, and February 3, 2025. Those adversely affected during this timeframe have until April 14, 2025, to assert their rights.

Details of the Case

The lawsuit aims to recover losses incurred by investors due to misrepresentations made by the company regarding its expected revenue from the vaccine Gardasil. According to the statement, Merck projected a revenue of $11 billion from Gardasil sales by 2030, citing a broad demand bolstered by effective marketing and consumer education. However, those optimistic reports were followed by significant corrections when Merck declared on February 4, 2025, that these expectations were no longer realistic. The announcement that shipments of Gardasil to China would cease for at least six months was a major red flag for the company’s stock.

Investors were shocked as Merck’s stock plummeted, experiencing a sharp decline of over 9% from $99.79 to $90.74 in just one day following these revelations.

Why Should Investors Act?

For investors who have experienced losses during the specified period, the court's upcoming deadline necessitates action. You can claim rights even without being appointed as the lead plaintiff. It's noteworthy that participating in this class action will incur no out-of-pocket costs or fees for investors, and there are no obligations involved in being part of the suit.

Levi & Korsinsky’s Track Record

With over 20 years of experience, Levi & Korsinsky has established a strong reputation in securities litigation. The firm has successfully recovered hundreds of millions of dollars for shareholders and is ranked among the Top 50 securities litigation firms in the U.S. by ISS Securities Class Action Services. Their dedicated team, consisting of more than 70 professionals, is committed to advocating for investors' rights.

Get In Touch

Investors interested in participating or seeking further information about the lawsuit can reach out to Joseph E. Levi, Esq. at Levi & Korsinsky via email or phone. Further details and the option to submit information are also available through their official website.

If you are a shareholder in Merck & Co., Inc., now is the time to consider your position and take action regarding this lawsuit. Your rights as an investor must be protected, and understanding your options can lead to potential recovery from losses incurred during the specified timeline.

Contact Information for Legal Inquiries
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500
Fax: (212) 363-7171
Website: www.zlk.com

Make sure your voice is heard, and consider joining this pivotal legal action against Merck.